Understanding blood clots and testing new treatments using advanced 3D models
High-throughput Imaging-integrated Vascular Model for Understanding Thromboembolism and Therapeutics Screening
This study is looking at how blood clots form and how we can treat them better, especially for people dealing with conditions like deep vein thrombosis and pulmonary embolism, using special 3D models that act like human cells to test new medications and see how they respond to infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10984461 on NIH RePORTER |
What this research studies
This research investigates how blood clots form and how they can be treated, focusing on a condition known as venous thromboembolism (VTE). By using advanced three-dimensional (3D) human cell models, the research aims to better mimic human physiology and improve the testing of new drugs. Patients may benefit from the development of more effective treatments for conditions related to blood clots, such as deep vein thrombosis and pulmonary embolism. The study will also monitor how these models respond to viral infections and drug treatments in real-time.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for venous thromboembolism, such as those with a history of deep vein thrombosis or pulmonary embolism.
Not a fit: Patients who do not have any history of blood clotting disorders or related conditions may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for blood clot-related conditions, potentially reducing mortality and improving patient outcomes.
How similar studies have performed: Other research has shown promise in using 3D models for drug testing, indicating that this approach could lead to significant advancements in treatment efficacy.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Zhang, Y. Shrike — Brigham and Women's Hospital
- Study coordinator: Zhang, Y. Shrike
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.